ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 73% specificity Salt Lake...
Read More
ProLung Promotes Jared Bauer from interim CEO to CEO Salt Lake City, UT, October 2, 2019...
Read MoreProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of...
Read More
ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by...
Read More
ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech...
Read More
ProLung Announces New Office Location as Anchor Tenant at 'The Labs at Northgate' – ProLung,...
Read More
ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma –...
Read More
ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc. Salt Lake...
Read More
ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review –...
Read More
ProLung Announces Voting Results from its 2018 Annual Meeting of Shareholders – ProLung, Inc. SALT LAKE...
Read MoreProLung Announces Final Results from its PL-209 Repeatability Study – ProLung, Inc. SALT LAKE CITY, UT...
Read MoreProLung Announces Preliminary Results of Consent Solicitation – ProLung, Inc. - Consent Solicitation Clearly Failed to...
Read More